US Stock MarketDetailed Quotes
ESLA Estrella Immunopharma
- 2.210
- +0.500+29.24%
Close Jul 26 16:00 ET
- 2.050
- -0.160-7.24%
Post 20:01 ET
80.39MMarket Cap-5525P/E (TTM)
3.230High1.880Low3.95MVolume1.880Open1.710Pre Close9.75MTurnover37.30%Turnover RatioLossP/E (Static)36.38MShares33.00052wk High9.44P/B23.42MFloat Cap0.81052wk Low--Dividend TTM10.60MShs Float33.000Historical High--Div YieldTTM78.95%Amplitude0.810Historical Low2.465Avg Price1Lot Size
Estrella Immunopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (Q2)Dec 31, 2022 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets | ||||||
| Cash, cash equivalents and short term investments | --4.73M | 214.11%9.05M | --22.14M | --2.88M | --4.09M | --0 |
| -Cash and cash equivalents | --4.73M | 214.11%9.05M | --22.14M | --2.88M | --4.09M | --0 |
| Receivables | --406.11K | --0 | --0 | ---- | ---- | ---- |
| -Notes receivable | --0 | --0 | --0 | ---- | ---- | ---- |
| -Other receivables | --406.11K | ---- | ---- | ---- | ---- | ---- |
| Prepaid assets | --3.5M | --401.25K | --138.77K | --0 | --833.33K | --0 |
| Restricted cash | ---- | ---- | --5.07M | ---- | ---- | ---- |
| Total current assets | --8.63M | 228.04%9.45M | --27.35M | --2.88M | --4.92M | --0 |
| Non current assets | ||||||
| Net PPE | ---- | ---- | ---- | --40K | ---- | ---- |
| -Gross PPE | ---- | ---- | ---- | --40K | ---- | ---- |
| Non current deferred assets | --0 | --0 | --0 | --134.38K | ---- | ---- |
| Total non current assets | --0 | --0 | --0 | --174.38K | --0 | --0 |
| Total assets | --8.63M | 209.31%9.45M | --27.35M | --3.05M | --4.92M | --0 |
| Liabilities | ||||||
| Current liabilities | ||||||
| Payables | --45.47K | -96.73%146K | --14.85M | --4.47M | --946.68K | ---- |
| -accounts payable | --0 | -98.21%77.08K | --9.34M | --4.31M | --945.59K | --0 |
| -Total tax payable | --45.08K | 1,571.41%45.08K | --44.4K | --2.7K | --1.1K | --0 |
| -Other payable | --391 | -84.37%23.84K | --5.47M | --152.53K | ---- | ---- |
| Current accrued expenses | --93.02K | --252.74K | --2.13M | ---- | ---- | ---- |
| Current debt and capital lease obligation | ---- | ---- | --300K | --32.4K | ---- | ---- |
| -Current debt | ---- | ---- | --300K | ---- | ---- | ---- |
| -Current capital lease obligation | ---- | ---- | ---- | --32.4K | ---- | ---- |
| Current liabilities | --138.49K | -91.14%398.73K | --17.28M | --4.5M | --946.68K | --0 |
| Non current liabilities | ||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | --17.6K | ---- | ---- |
| -Long term capital lease obligation | ---- | ---- | ---- | --17.6K | ---- | ---- |
| Preferred securities outside stock equity | --0 | --0 | --0 | --5M | --5M | --0 |
| Other non current liabilities | ---- | ---- | ---- | --13.78K | --14.83K | ---- |
| Total non current liabilities | --0 | --0 | --0 | --5.03M | --5.01M | --0 |
| Total liabilities | --138.49K | -95.82%398.73K | --17.28M | --9.53M | --5.96M | --0 |
| Shareholders'equity | ||||||
| Share capital | --3.66K | 2,761.79%3.52K | --3.52K | --123 | --18 | --0 |
| -common stock | --3.66K | 2,761.79%3.52K | --3.52K | --123 | --18 | --0 |
| Retained earnings | ---15.55M | -124.54%-15.08M | ---14.06M | ---6.72M | ---1.07M | --0 |
| Paid-in capital | --24.12M | 9,950.57%24.12M | --24.12M | --240.03K | --34.29K | --0 |
| Less: Treasury stock | --84.09K | ---- | ---- | ---- | ---- | ---- |
| Total stockholders'equity | --8.49M | 239.73%9.05M | --10.07M | ---6.48M | ---1.04M | --0 |
| Total equity | --8.49M | 239.73%9.05M | --10.07M | ---6.48M | ---1.04M | --0 |
| Currency Unit | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
